หมวดหมู่: CISION PR Newswire – English Feeds
-
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
Oral presentation of DZD6008 demonstrated strong and du…
-
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
CHENGDU, China, May 31, 2026 /PRNewswire/ — Sichuan Ke…
-
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
CHENGDU, China, May 31, 2026 /PRNewswire/ — Sichuan Ke…
-
Cyient Enters Agreement to Acquire TAO Digital
Acquisition enhances Cyient’s offering portfolio with A…
-
Cyient Enters Agreement to Acquire TAO Digital
Acquisition enhances Cyient’s offering portfolio with A…
-
THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Millions of fans from across the world tuned in to watc…
-
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
CHENGDU, China, May 30, 2026 /PRNewswire/ — Sichuan Ke…
-
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
CHENGDU, China, May 30, 2026 /PRNewswire/ — Sichuan Ke…
-
Duke-NUS graduates biggest class yet, with new doctors drawn from business, engineering and the humanities
At his first graduation as Dean, Patrick Tan presides o…
-
The 7th China-CEEC Local Leaders’ Meeting and 2026 Shandong International Friendship Cities Cooperation and Exchange Week Successfully Held
JINAN, China, May 30, 2026 /PRNewswire/ — From May 25 …